These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11417664)

  • 1. Motor instability in parkinsonian speech intensity.
    Ho AK; Iansek R; Bradshaw JL
    Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):109-16. PubMed ID: 11417664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. For better or worse: The effect of levodopa on speech in Parkinson's disease.
    Ho AK; Bradshaw JL; Iansek R
    Mov Disord; 2008 Mar; 23(4):574-80. PubMed ID: 18163453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of dysprosody in Parkinson's disease over time--a longitudinal study.
    Skodda S; Rinsche H; Schlegel U
    Mov Disord; 2009 Apr; 24(5):716-22. PubMed ID: 19117364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of levodopa on word intelligibility in Parkinson's disease.
    De Letter M; Santens P; Van Borsel J
    J Commun Disord; 2005; 38(3):187-96. PubMed ID: 15748723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.
    Goberman AM
    Med Sci Monit; 2005 Mar; 11(3):CR109-16. PubMed ID: 15735562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Articulatory movements during vowels in speakers with dysarthria and healthy controls.
    Yunusova Y; Weismer G; Westbury JR; Lindstrom MJ
    J Speech Lang Hear Res; 2008 Jun; 51(3):596-611. PubMed ID: 18506038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence heterogeneity in Parkinsonian speech.
    Ho AK; Bradshaw JL; Cunnington R; Phillips JG; Iansek R
    Brain Lang; 1998 Aug; 64(1):122-45. PubMed ID: 9675046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of speech task on intelligibility in dysarthria: a case study of Parkinson's disease.
    Kempler D; Van Lancker D
    Brain Lang; 2002 Mar; 80(3):449-64. PubMed ID: 11896652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease.
    De Letter M; Santens P; De Bodt M; Van Maele G; Van Borsel J; Boon P
    Clin Neurol Neurosurg; 2007 Jul; 109(6):495-500. PubMed ID: 17509751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intonation and speech rate in Parkinson's disease: general and dynamic aspects and responsiveness to levodopa admission.
    Skodda S; Grönheit W; Schlegel U
    J Voice; 2011 Jul; 25(4):e199-205. PubMed ID: 21051196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Speech dysfunction in early Parkinson's disease.
    Stewart C; Winfield L; Hunt A; Bressman SB; Fahn S; Blitzer A; Brin MF
    Mov Disord; 1995 Sep; 10(5):562-5. PubMed ID: 8552106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease.
    Pinto S; Gentil M; Fraix V; Benabid AL; Pollak P
    J Neurol; 2003 Feb; 250(2):179-87. PubMed ID: 12574948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech.
    Pinto S; Gentil M; Krack P; Sauleau P; Fraix V; Benabid AL; Pollak P
    Mov Disord; 2005 Nov; 20(11):1507-15. PubMed ID: 16037917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
    Parkinson Study Group
    Arch Neurol; 2005 Feb; 62(2):241-8. PubMed ID: 15710852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain intensity on and off levodopa in patients with Parkinson's disease.
    Nebe A; Ebersbach G
    Mov Disord; 2009 Jun; 24(8):1233-7. PubMed ID: 19412949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate and loudness manipulations in dysarthria: acoustic and perceptual findings.
    Tjaden K; Wilding GE
    J Speech Lang Hear Res; 2004 Aug; 47(4):766-83. PubMed ID: 15324285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of apraxic speech to working memory deficits in Parkinson's disease.
    Howard LA; Binks MG; Moore AP; Playfer JR
    Brain Lang; 2000 Sep; 74(2):269-88. PubMed ID: 10950919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
    Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
    Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hand coordination as a quantitative measure of motor abnormality and therapeutic response in Parkinson's disease.
    Benice TS; Lou JS; Eaton R; Nutt J
    Clin Neurophysiol; 2007 Aug; 118(8):1776-84. PubMed ID: 17576094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subthalamic stimulation in Parkinson disease: with or without anesthesia?
    Maltête D; Navarro S; Welter ML; Roche S; Bonnet AM; Houeto JL; Mesnage V; Pidoux B; Dormont D; Cornu P; Agid Y
    Arch Neurol; 2004 Mar; 61(3):390-2. PubMed ID: 15023817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.